<!DOCTYPE html><html lang="en"><head><meta name="generator" content="Scully 0.0.0">
  <meta charset="utf-8">
  <title>NgxGardSkully 123</title>
  <base href="/">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
<link rel="stylesheet" href="styles.4cdd1989b7928c8b693d.css"><style>body,html{overflow-x:hidden}@media (max-width:991.98px){.offcanvas-collapse{position:fixed;top:56px;bottom:0;left:100%;width:100%;padding-right:1rem;padding-left:1rem;overflow-y:auto;visibility:hidden;background-color:#343a40;transition:transform .3s ease-in-out,visibility .3s ease-in-out}.offcanvas-collapse.open{visibility:visible;transform:translateX(-100%)}}.nav-scroller{position:relative;z-index:2;height:2.75rem;overflow-y:hidden}.nav-scroller .nav{display:flex;flex-wrap:nowrap;padding-bottom:1rem;margin-top:-1px;overflow-x:auto;color:hsla(0,0%,100%,.75);text-align:center;white-space:nowrap;-webkit-overflow-scrolling:touch}.nav-underline .nav-link{padding-top:.75rem;padding-bottom:.75rem;font-size:.875rem;color:#6c757d}.nav-underline .nav-link:hover{color:#007bff}.nav-underline .active{font-weight:500;color:#343a40}.text-white-50{color:hsla(0,0%,100%,.5)}.bg-purple{background-color:#6f42c1}.lh-100{line-height:1}.lh-125{line-height:1.25}.lh-150{line-height:1.5}.splitter{margin-left:20px;margin-right:20px;display:inline-block;font-size:20px;transform:scaleX(.3)}.banner{background-color:#1b5b76;height:116px;background-image:url(https://rarediseases.info.nih.gov/content/images/banner-touch-diseases.jpg);background-repeat:no-repeat;background-position:100%}.search-ct{top:40px;left:30px}.footer{background:#d3d3d3;height:230px}.footer-links{padding-top:20px}.footer-text{margin-top:30px;text-align:center}.input-group-text{cursor:pointer}</style><style></style><script>window['ScullyIO']='generated';</script></head>
<body scully-version="0.0.0">
  <app-root ng-version="10.0.14"><nav class="navbar navbar-dark sticky-top bg-dark flex-md-nowrap p-0 shadow"><span class="shrink-width"><ul class="navbar-nav px-3 list-inline"><li class="nav-item text-nowrap list-inline-item"><span href="#" class="nav-link">U.S. Department of Health &amp; Human Services <span class="splitter"> &gt; </span> National Institutes of Health <span class="splitter"> &gt; </span> NCATS</span></li></ul></span></nav><div class="shrink-width"><div class="nav-scroller bg-white shadow-sm justify-content-center"><nav class="nav nav-underline"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">Diseases</a><a routerlink="/help" routerlinkactive="active" class="nav-link" href="/help">Guides</a><a routerlink="/news" routerlinkactive="active" class="nav-link" href="/news">News</a><a routerlink="/about" routerlinkactive="active" class="nav-link" href="/about">About GARD</a><a routerlink="/espanol" routerlinkactive="active" class="nav-link" href="/espanol">En Espanõl</a></nav></div><form novalidate="" class="ng-untouched ng-pristine ng-valid"><div class="banner"><div class="col-md-6 search-ct"><div class="input-group mb-3"><input formcontrolname="search" type="text" placeholder="Search for Diseases, Organizations, News and More..." aria-label="Search for Diseases, Organizations, News and More..." aria-describedby="basic-addon2" class="form-control ng-untouched ng-pristine ng-valid"><span class="input-group-text">GO</span></div></div></div></form><div class="container-fluid"><router-outlet></router-outlet><app-disease-details><div class="row"><div class="col-md-3"><nav><div class="sidebar-sticky pt-3"><ul class="nav flex-column"><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Browse A-Z </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Find Diseases By Category </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> List of FDA Orphan Drugs </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> GARD Information Navigator </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> FAQs About Rare Diseases </a></li></ul></div></nav></div><main role="main" class="col-md-9"><div class="d-flex justify-content-between flex-wrap flex-md-nowrap align-items-center pt-3 pb-2 mb-3 border-bottom"><h1 class="h2">Disease # 8391 - Ornithine transcarbamylase deficiency</h1></div><div><p><b>Other Names: </b>Ornithine carbamoyltransferase deficiency, OTC deficiency, OTCD</p><p><b>Categories: </b><span> Congenital and Genetic Diseases</span><span> Metabolic disorders</span><span> Nervous System Diseases</span><span> Newborn Screening</span><!----></p><p><b>This disease is grouped under: </b>Urea cycle disorders</p><p><b>Summary: </b><span><strong>Ornithine transcarbamylase (OTC) deficiency</strong> is a genetic disease that causes too much ammonia to accumulate in the blood (hyperammonemia). Ammonia is toxic when levels are too high and especially affects the nervous system.<br>
<br>
Severe OTC deficiency (the early-onset form) typically affects males (and rarely females) and causes symptoms in the newborn period or early childhood. Signs and symptoms of this form may include lack of energy and appetite, poorly-controlled breathing rate and body temperature, unusual body movements, seizures, or coma. When not treated, the disease can lead to development delay, <a href="http://www.nlm.nih.gov/medlineplus/ency/article/001523.htm" target="_blank">intellectual disability</a>, and liver damage. Less frequently, symptoms of OTC deficiency begin later in life (the late-onset form) and are less severe. This form occurs in both males and females. Symptoms of this form may include episodes of  delirium, erratic behavior, a reduced level of consciousness, headaches, vomiting, and seizures.[7149]<br>
<br>
OTC is caused by <a href="http://www.genome.gov/Glossary/index.cfm?id=134" target="_blank">mutations</a>&nbsp;in the <span class="geneSymbol"><a href="http://www.ghr.nlm.nih.gov/gene/OTC" target="_blank" tabindex="-1"><em>OTC</em></a></span>&nbsp;gene and inheritance is&nbsp;<a href="http://www.genome.gov/Glossary/index.cfm?id=209" target="_blank" tabindex="-1">X-linked</a>.[7149] Treatment involves removing protein from the diet, taking certain medications, and having <a href="https://www.kidney.org/atoz/content/hemodialysis" target="_blank" tabindex="-1">hemodialysis</a>&nbsp;if needed for extremely high blood ammonia levels.[7147]</span></p><div><b>Organizations: </b><ul><li><span><a href="org.url">Metabolic Support UK</a></span><br><span>5 Hilliards Court</span><br><span>Chester , CH4 9QP</span><br><!----><!----></li><li><span><a href="org.url">National Urea Cycle Disorders Foundation</a></span><br><span>75 South Grand Avenue</span><br><span>Pasadena CA, 91105</span><br><!----><!----></li><li><span><a href="org.url">The Brí Foundation</a></span><br><!----></li><!----></ul></div><div><b>Learn More</b><ul><li><span><a href="http://www.omim.org/311250" target="_blank">Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br>
</span></li><li><span><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%28%222000/01/01%22%5BPDAT%5D%20%3A%20%223000%22%5BPDAT%5D%29%20AND%20%28%22ornithine%20carbamoyltransferase%20deficiency%20disease%22%5BMeSH%20Terms%5D%20OR%20%28%22ornithine%22%5BAll%20Fields%5D%20AND%20%22carbamoyltransferase%22%5BAll%20Fields%5D%20AND%20%22deficiency%22%5BAll%20Fields%5D%20AND%20%22disease%22%5BAll%20Fields%5D%29%20OR%20%22ornithine%20carbamoyltransferase%20deficiency%20disease%22%5BAll%20Fields%5D%20OR%20%28%22ornithine%22%5BAll%20Fields%5D%20AND%20%22transcarbamylase%22%5BAll%20Fields%5D%20AND%20%22deficiency%22%5BAll%20Fields%5D%29%20OR%20%22ornithine%20transcarbamylase%20deficiency%22%5BAll%20Fields%5D%29%20AND%20%28%28Clinical%20Trial%5Bptyp%5D%20OR%20Editorial%5Bptyp%5D%20OR%20Letter%5Bptyp%5D%20OR%20Meta-Analysis%5Bptyp%5D" target="_blank">PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Ornithine transcarbamylase deficiency. Click on the link to view a sample search on this topic.</span></li><li><span><a href="http://www.clinicaltrials.gov/ct2/results?cond=%22Ornithine+transcarbamylase+deficiency%22" target="_blank">ClinicalTrials.gov</a> lists trials that are related to Ornithine transcarbamylase deficiency. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br>
<br>
<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em></span></li><li><span><a href="http://ghr.nlm.nih.gov/condition/ornithine-transcarbamylase-deficiency" target="_blank">Genetics Home Reference (GHR)</a> contains information on Ornithine transcarbamylase deficiency. This website is maintained by the National Library of Medicine.<br>
</span></li><li><span><a href="http://www.nucdf.org/events.htm " target="_blank">Reaching for a Cure: 2011 NUCDF Annual Conference</a>, July 8 2011 - July 10, 2011&nbsp;<br><strong>Location: </strong>Sheraton Denver Downtown, Denver, Colorado <br><strong>Description:&nbsp;</strong>This conference offers the&nbsp;unique opportunity to meet other UCD families, stay informed, and learn about new advances in research, treatment and management to improve the lives of children and adults with UCD. Working together, our NUCDF families and community of committed researchers and medical professionals are making a major impact with advances in the understanding of UCDs, accelerating research, and improved outcomes in children and adults with UCD. In the past four years, research for UCDs has increased by 400%! Let's continue the momentum and end the devastating effects of UCD. </span></li><li><span><p>The <a href="https://www.rarediseasesnetwork.org/cms/ucdc" target="_blank">Urea Cycle Disorders Consortium</a> is a team of doctors, nurses, research coordinators, and research labs throughout the US, working together to improve the lives of people with Urea Cycle Disorders. The Urea Cycle Disorders Consortium maintains a registry for patients who wish to&nbsp;be contacted about clinical research opportunities. </p><p>For more information on the registry see: <a href="http://rarediseasesnetwork.epi.usf.edu/ucdc/takeaction/index.htm " target="_blank">http://rarediseasesnetwork.epi.usf.edu/ucdc/takeaction/index.htm</a> </p></span></li><li><span><a href="https://www.ncbi.nlm.nih.gov/books/NBK1217/" target="_blank">GeneReviews</a> provides a current, expert-authored, peer-reviewed, full-text article urea cycle disorders in general that you may find helpful. GeneReview articles describe the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.</span></li><li><span><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000372.htm " target="_blank">MedlinePlus.gov</a> provides more information on urea cycle disorders in general. MedlinePlus is a Web site designed by the National Library of Medicine to help you research your health questions.</span></li><li><span>Scaglia, et al. <a href="http://pediatrics.aappublications.org/cgi/reprint/109/1/150?maxtoshow=&amp;amp;HITS=10&amp;amp;hits=10&amp;amp;RESULTFORMAT=&amp;amp;fulltext=ornithine&amp;amp;searchid=1&amp;amp;FIRSTINDEX=0&amp;amp;volume=109&amp;amp;issue=1&amp;amp;resourcetype=HWCIT " target="_blank">An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency</a>. Pediatrics 2002;109:150-152.</span></li><li><span>Riudor, et al.&nbsp; <a href="http://pediatrics.aappublications.org/cgi/reprint/111/5/1123-a?maxtoshow=&amp;amp;amp;HITS=10&amp;amp;amp;hits=10&amp;amp;amp;RESULTFORMAT=&amp;amp;amp;fulltext=ornithine&amp;amp;amp;searchid=1&amp;amp;amp;FIRSTINDEX=0&amp;amp;amp;volume=111&amp;amp;amp;issue=5&amp;amp;amp;resourcetype=HWCIT " target="_blank">Partial Ornithine Transcarbamylase Deficiency</a>. Pediatrics 2003;111:1123-1124.</span></li><li><span>To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href="http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx" target="_blank">American College of Medical Genetics</a> and the&nbsp;<a href="https://www.findageneticcounselor.com/" target="_blank">National Society of Genetic Counselors</a>. If you need additional help, <a href="https://rarediseases.info.nih.gov/about-gard/contact-gard">contact a GARD Information Specialist</a>. You can also&nbsp;<a href="https://ghr.nlm.nih.gov/primer#consult" target="_blank">learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.</span></li><li><span>The <a href="http://www.ncbi.nlm.nih.gov/gtr/conditions/C0268542" target="_blank">Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br>
</span></li><li><span>The <a href="http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/309/viewAbstract" target="_blank">National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br>
</span></li><li><span><a href="https://emedicine.medscape.com/article/950672-overview?pa=V%2FSdfyjWjIwnnIdJgch6ptpQ6HfAWVyTbdnW1msmA3vDQao803J%2BDXuZXgD6rN0sNFsYxDuz%2Fz2hge3aAwEFsw%3D%3D" target="_blank">Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br>
</span></li><li><span>The <a href="https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022250" target="_blank">Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href="http://www.ssa.gov/compassionateallowances/index.htm" target="_blank">Compassionate Allowances</a> and <a href="https://www.ssa.gov/benefits/disability/" target="_blank">applying for Social Security disability</a> is available online.</span></li><li><span><a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=664" target="_blank">Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br>
</span></li><li><span><a href="https://www.orpha.net/data/patho/Pro/en/Emergency_BIMDG_CPS-OTCdeficiency-enPro461.pdf" target="_blank">Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;</span></li><li><span>The <a href="https://rarediseases.org/physician-guide/urea-cycle-disorders/" target="_blank">NORD Physician Guide</a> for Ornithine transcarbamylase deficiency was developed as a free service of the National Organization for Rare Disorders (NORD) and it's medical advisors. &nbsp;The guides provide a resource for clinicians about specific rare disorders to facilitate diagnosis and treatment of their patients with this condition.&nbsp;</span></li><li><span>The <a href="http://www.gemssforschools.org/conditions/urea-cycle/default" target="_blank">Genetics Education Materials for School Success (GEMSS)</a> aims to assure that all children with genetic health conditions succeed in school-life. Their Web site offers general and condition-specific education resources to help teachers and parents better understand the needs of students who have genetic conditions.</span></li><li><span>The <a href="https://monarchinitiative.org/disease/OMIM:311250" target="_blank">Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.</span></li><li><span>The <a href="http://www.healthwellfoundation.org/urea-cycle-disorders" target="_blank">HealthWell Foundation</a> provides financial assistance for underinsured patients living with chronic and life-altering conditions. They offer help with drug copayments, deductibles, and health insurance premiums for patients with specific diseases. The disease fund status can change over time, so you may need to check back if funds are not currently available.</span></li><li><span><a href="https://www.mygooddays.org/patients/diseases-covered/chronic-iron-overload" target="_blank">Good Days</a> provides help to patients with life-altering conditions. Assistance includes help with the cost of medications and travel.</span></li><!----></ul></div></div></main><!----></div></app-disease-details><!----></div></div><div class="footer"><div class="shrink-width"><div class="footer-links row align-items-center"><div class="col"><a href="/" target="_self">GARD Home</a></div><div class="col"><a href="http://ncats.nih.gov/">NCATS Home</a></div><div class="col"><a href="javascript: void(0)">Site Map</a></div><div class="col"><a href="javascript: void(0)">Browse Glossary A-Z</a></div><div class="col"><a href="javascript: void(0)">Privacy Notice</a></div><div class="col"><a href="javascript: void(0)">Disclaimer</a></div><div class="col"><a href="javascript: void(0)">Accessibility</a></div><div class="col"><a href="javascript: void(0)">FOIA </a></div><div class="col"><a href="javascript: void(0)">OIG</a></div></div><div class="footer-text"><p> If you have problems viewing PDF files, download the latest version of <a target="_blank" href="https://get.adobe.com/reader/" class="footer-links">Adobe Reader</a></p><p> For <a f="http://edi.nih.gov/consulting/language-access-program/about" target="_blank" title="Read the plan" class="ext">language access</a> assistance, contact the <a href="mailto: info@ncats.nih.gov" title="E - mail Public Information Officer" class="footer-links">NCATS Public Information Officer</a></p><p> Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311 </p></div></div></div></app-root>
<script src="runtime.e227d1a0e31cbccbf8ec.js" defer=""></script><script src="polyfills.1aefc75bf7d5acb269d2.js" defer=""></script><script src="main.f870601fdb5bc988c829.js" defer=""></script>
<script id="ScullyIO-transfer-state"></script><script src="js/custom.js"></script>

</body></html>